Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis

被引:25
作者
Choe, Jung-Yoon [1 ]
Lee, Hwajeong [1 ]
Jung, Hyun-Young [1 ]
Park, Sung-Hoon [1 ]
Bae, Sang-Cheol [2 ]
Kim, Seong-Kyu [1 ]
机构
[1] Catholic Univ Daegu, Sch Med, Arthrit & Autoimmun Res Ctr, Dept Internal Med, Taegu 705718, South Korea
[2] Hanyang Univ, Coll Med, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea
关键词
Methotrexate; Methylenetetrahydrofolate reductase; Polymorphism; Toxicity; Rheumatoid arthritis; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC RISK-FACTOR; THERAPY; MTHFR; EFFICACY; MUTATION; DISEASE; ENZYMES; UPDATE;
D O I
10.1007/s00296-011-1989-5
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
We investigated associations between the methylenetetrahydrofolate reductase (MTHFR) polymorphisms C677T and A1298C and methotrexate (MTX)-related toxicities in Korean patients with rheumatoid arthritis (RA) taking MTX. One hundred sixty-seven patients with RA were enrolled in a cross-sectional study and genotyped for the single-nucleotide polymorphisms C677T and A1298C in MTHFR. Alleles, genotypes, and haplotypes of the C677T and A1298C polymorphisms were not associated with specific MTX toxicities. However, among RA patients with the 1298CC genotype, the proportion who experienced at least one toxicity was significantly greater than the proportion of patients with 1298AA who did (P = 0.043). In addition, the proportion of patients with the 677C/1298A haplotype who experienced toxicity was greater than the proportion of those with 677C/1298C who did (P = 0.032, odds ratio = 2.085, 95% confidence interval 1.058-4.106). In this study, MTHFR polymorphisms were associated with MTX toxicities in Korean patients with RA. Further study for association of MTHFR polymorphisms with MTX toxicities should be needed in larger RA population.
引用
收藏
页码:1837 / 1842
页数:6
相关论文
共 26 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]
BAGGOTT JE, 1993, CLIN EXP RHEUMATOL, V11, pS101
[3]
Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene [J].
Berkun, Y ;
Levartovsky, D ;
Rubinow, A ;
Orbach, H ;
Aamar, S ;
Grenader, T ;
Abou Atta, I ;
Mevorach, D ;
Friedman, G ;
Ben-Yehuda, A .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1227-1231
[4]
A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[5]
HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE - ISOLATION OF CDNA, MAPPING AND MUTATION IDENTIFICATION [J].
GOYETTE, P ;
SUMNER, JS ;
MILOS, R ;
DUNCAN, AMV ;
ROSENBLATT, DS ;
MATTHEWS, RG ;
ROZEN, R .
NATURE GENETICS, 1994, 7 (02) :195-200
[6]
THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY .2. EFFECT OF AMINOPTERIN IN RHEUMATOID ARTHRITIS AND PSORIASIS [J].
GUBNER, R ;
AUGUST, S ;
GINSBERG, V .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1951, 221 (02) :176-182
[7]
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis [J].
Haagsma, CJ ;
Blom, HJ ;
van Riel, PLCM ;
van't Hof, MA ;
Giesendorf, BAJ ;
van Oppenraaij-Emmerzaal, D ;
van de Putte, LBA .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (02) :79-84
[8]
Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis [J].
Hughes, L. B. ;
Beasley, T. M. ;
Patel, H. ;
Tiwari, H. K. ;
Morgan, S. L. ;
Baggott, J. E. ;
Saag, K. G. ;
McNicholl, J. ;
Moreland, L. W. ;
Alarcon, G. S. ;
Bridges, S. L., Jr. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) :1213-1218
[9]
Kim SK, 2006, J RHEUMATOL, V33, P1266
[10]
Kumagai K, 2003, INT J MOL MED, V11, P593